The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cerevel Therapeutics Holdings Inc’s current trading price is -32.82% away from its 52-week high, while its distance from the 52-week low is 23.38%. The stock’s price range for this period has been between $19.59 and $35.98 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.83 million for the day, a number notably lower than the average daily volume of 0.85 million over the last three months.
The present stock price for Cerevel Therapeutics Holdings Inc (CERE) is $24.17. In the last trading session, the stock made a considerable jump, reaching $25.375 after an opening price of $25.21. The stock briefly fell to $24.112 before ending the session at $25.46.
The market performance of Cerevel Therapeutics Holdings Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $35.98 on 06/16/23, while the lowest value for the same duration was $19.59 on 10/04/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cerevel Therapeutics Holdings Inc (CERE) has experienced a quarterly rise of 14.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.36B and boasts a workforce of 298 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 24.71, with a change in price of -8.25. Similarly, Cerevel Therapeutics Holdings Inc recorded 794,952 in trading volume during the last 100 days, posting a change of -25.45%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CERE stands at 1.73. Similarly, the long-term debt-to-equity ratio is also 1.72.
CERE Stock Stochastic Average
As of today, Cerevel Therapeutics Holdings Inc’s raw stochastic average for the last 50 days stands at 66.47%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 46.65%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 56.89% and 54.41%, respectively.
CERE Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -23.37% this year. Over the last six months, there has been a stronger performance of -23.71%. The price of CERE fallen by 6.34% during the last 30 days period. For the last 5-days stocks have slided -1.23%.